查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1703418

藥物洗脫支架市場－全球產業規模、佔有率、趨勢、機會和預測，按塗層類型（聚合物基塗層）、無聚合物塗層、按應用、按地區和競爭細分，2020-2030 年

Drug Eluting Stent Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Coating Type (Polymer-based Coatings, Polymer-free Coatings), By Application, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球藥物洗脫支架 (DES) 市場價值為 83 億美元，預計將經歷強勁成長，到 2030 年年複合成長率(CAGR) 為 8.08%。全球醫療保健領域的重大進步（尤其是在技術和創新方面）在提高患者護理和治療效果方面發揮了關鍵作用。在這些進步中，藥物洗脫支架已成為介入性心臟病學的變革性解決方案。這些雖小卻至關重要的醫療設備正在徹底改變冠狀動脈疾病 (CAD) 的管理，從而推動全球 DES 市場的顯著擴張。

市場概覽
預測期 2026-2030
2024年市場規模 83億美元
2030年市場規模 132.6億美元
2025-2030 年複合年成長率 8.08%
成長最快的領域 聚合物基塗料
最大的市場 北美洲

藥物洗脫支架是用於治療冠狀動脈疾病和降低動脈再次狹窄可能性的專用醫療設備。 DES 由塗有抗再狹窄藥物的金屬網管組成，既可作為維持動脈通暢的結構支撐，也可作為控制藥物釋放的輸送系統。這種雙重功能有助於防止在狹窄或阻塞的冠狀動脈中植入後出現再狹窄。

關鍵市場促進因素

全球人口老化

主要市場挑戰

監管障礙

主要市場趨勢

技術進步

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：藥物洗脫支架市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依塗層類型（聚合物基塗層（非生物分解，可生物分解）），無聚合物塗層（微孔表面，微結構表面，開槽管狀表面，奈米多孔表面））
    • 依應用（冠狀動脈疾病、周邊動脈疾病）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美藥物洗脫支架市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲藥物洗脫支架市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太藥物洗脫支架市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美藥物洗脫支架市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲藥物洗脫支架市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球藥物洗脫支架市場：SWOT 分析

第 14 章：競爭格局

  • Abbott Laboratories Ltd.
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic plc
  • Biosensors International Ltd
  • Cook Medical pvt ltd.
  • B. Braun Medical (India) Private Limited
  • Biotronik, Inc.
  • Lepu Medical Technology Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16359

Global Drug-eluting stent (DES) market was valued at USD 8.30 billion in 2024 and is projected to experience robust growth, with a compound annual growth rate (CAGR) of 8.08% through 2030. Significant advancements within the global healthcare sector-particularly in technology and innovation-have played a critical role in enhancing patient care and treatment outcomes. Among these advancements, drug-eluting stents have emerged as a transformative solution in interventional cardiology. These small yet vital medical devices are revolutionizing the management of coronary artery disease (CAD), thereby fueling notable expansion in the global DES market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 8.30 Billion
Market Size 2030USD 13.26 Billion
CAGR 2025-20308.08%
Fastest Growing SegmentPolymer-based Coatings
Largest MarketNorth America

Drug-eluting stents are specialized medical devices used to treat coronary artery disease and reduce the likelihood of arterial re-narrowing. Comprising a metallic mesh tube coated with an anti-restenotic drug, DES function both as a structural support to maintain arterial patency and as a delivery system for controlled drug release. This dual function helps prevent restenosis following implantation in narrowed or blocked coronary arteries..

Key Market Drivers

Aging Global Population

The growing elderly population is a major driver of the DES market, as older individuals are more vulnerable to cardiovascular diseases, particularly CAD. With global life expectancy on the rise, demand for minimally invasive cardiac treatments is expected to increase. According to the World Health Organization, the global population aged 60 and above is expected to grow from 1 billion in 2020 to 1.4 billion by 2030 and reach 2.1 billion by 2050. The 80+ age group is also set to triple, rising to 426 million by 2050. This demographic shift has far-reaching implications for healthcare providers and device manufacturers, as cardiovascular treatments such as DES become increasingly essential.

Key Market Challenges

Regulatory Hurdles

One of the primary challenges for the DES market is the constantly evolving regulatory landscape. Regulatory bodies across various regions frequently revise guidelines governing medical devices. As a result, manufacturers must allocate significant resources to ensure ongoing compliance. Securing approvals for new or modified products can be both time-intensive and costly, potentially delaying market entry and impacting profitability.

Key Market Trends

Technological Advancements

Technological innovation is significantly reshaping the global healthcare landscape, with drug-eluting stents at the forefront of progress in interventional cardiology. One of the most notable advancements is the use of biocompatible polymers that optimize drug release kinetics and reduce adverse patient reactions such as inflammation or allergies.

In addition, bioabsorbable stents represent a cutting-edge development. Designed to gradually dissolve within the body, these stents eliminate the long-term complications often associated with permanent metal implants, such as late-stage thrombosis. These innovations are expected to enhance treatment outcomes and further stimulate market growth in the coming years.

Key Market Players

  • Abbott Laboratories ltd.
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic plc
  • Biosensors International Ltd
  • Cook Medical pvt ltd.
  • B. Braun Medical (India) Private Limited
  • Biotronik, Inc.
  • Lepu Medical Technology Inc.

Report Scope:

In this report, the Global Drug Eluting Stent Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Drug Eluting Stent Market, By Coating Type:

  • Polymer-based Coatings
  • Polymer-free Coatings

Drug Eluting Stent Market, By Application:

  • Coronary Artery Disease
  • Peripheral Artery Disease

Drug Eluting Stent Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Drug Eluting Stent Market.

Available Customizations:

Global Drug Eluting Stent market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Drug Eluting Stent Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Coating Type (Polymer-based Coatings (Non-biodegradable, Biodegradable)), Polymer-free Coatings (Micro porous Surface, Micro structured Surface, Slotted tubular Surface, Nanoporous Surface))
    • 5.2.2. By Application (Coronary Artery Disease, Peripheral Artery Disease)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Drug Eluting Stent Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Coating Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Drug Eluting Stent Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Coating Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Drug Eluting Stent Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Coating Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Drug Eluting Stent Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Coating Type
        • 6.3.3.2.2. By Application

7. Europe Drug Eluting Stent Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Coating Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Drug Eluting Stent Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Coating Type
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Drug Eluting Stent Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Coating Type
        • 7.3.2.2.2. By Application
    • 7.3.3. Italy Drug Eluting Stent Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Coating Type
        • 7.3.3.2.2. By Application
    • 7.3.4. France Drug Eluting Stent Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Coating Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Drug Eluting Stent Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Coating Type
        • 7.3.5.2.2. By Application

8. Asia-Pacific Drug Eluting Stent Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Coating Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Drug Eluting Stent Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Coating Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Drug Eluting Stent Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Coating Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Drug Eluting Stent Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Coating Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Drug Eluting Stent Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Coating Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Drug Eluting Stent Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Coating Type
        • 8.3.5.2.2. By Application

9. South America Drug Eluting Stent Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Coating Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Drug Eluting Stent Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Coating Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Drug Eluting Stent Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Coating Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Drug Eluting Stent Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Coating Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Drug Eluting Stent Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Coating Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Drug Eluting Stent Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Coating Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Drug Eluting Stent Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Coating Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Drug Eluting Stent Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Coating Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Drug Eluting Stent Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Abbott Laboratories Ltd.
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Boston Scientific Corporation
  • 14.3. Terumo Corporation
  • 14.4. Medtronic plc
  • 14.5. Biosensors International Ltd
  • 14.6. Cook Medical pvt ltd.
  • 14.7. B. Braun Medical (India) Private Limited
  • 14.8. Biotronik, Inc.
  • 14.9. Lepu Medical Technology Inc.

15. Strategic Recommendations

16. About Us & Disclaimer